Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2004
10/21/2004WO2004090550A2 A method for detection of colorectal cancer in human samples
10/21/2004WO2004090549A1 Method of screening for secreted glycosylated polypeptides
10/21/2004WO2004090548A1 Device for analysis or separation containing an active nanostructured carrier, its preparation method and applications
10/21/2004WO2004090547A2 Metastatic colorectal cancer signatures
10/21/2004WO2004090546A1 Identifying a midregional proadrenomedullin partial peptide in biological liquids for diagnostic purposes, and immunoassays for conducting an identification of this type
10/21/2004WO2004090545A2 Methods for treating proliferative diseases and for monitoring the effectiveness of treatment of proliferative diseases
10/21/2004WO2004090544A2 Detection, characterization and treatment of viral infection and methods thereof
10/21/2004WO2004090543A1 Assay method
10/21/2004WO2004090542A1 Protein array and process for producing the same
10/21/2004WO2004090541A1 METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR AND DRUG OBTAINED THEREBY
10/21/2004WO2004090540A1 Method of fixing low-molecular compound to solid-phase support
10/21/2004WO2004090539A2 Methods of determining efficacy of treatments of inflammatory diseases of the bowel
10/21/2004WO2004090537A2 Methods to individualize combination therapy
10/21/2004WO2004090536A1 Method of analysing the cytoskeletal protein of cells
10/21/2004WO2004090535A1 Murine living tissue model & uses thereof
10/21/2004WO2004090534A1 Non-invasive breath analysis using field asymmetric ion mobility spectrometry
10/21/2004WO2004090533A1 Biosensor system
10/21/2004WO2004090532A1 Method of determining xenograft responses
10/21/2004WO2004090531A1 Device for the delivery of two gases to an analyzing device
10/21/2004WO2004090525A1 Steroid hormone analysis by mass spectrometry
10/21/2004WO2004090519A1 Method of measuring freshness of cereals and beans and appratus therefor
10/21/2004WO2004090515A1 Method of measuring protein solubility, process for producing crystal and apparatus therefor
10/21/2004WO2004090512A1 Optical chemical sensing device with pyroelectric or piezoelectric transducer
10/21/2004WO2004090506A2 Surfaces that selectively bind to moieties
10/21/2004WO2004090168A1 Multiplexed cell analysis system
10/21/2004WO2004090165A1 Surface immobilised multilayer structure of vesicles
10/21/2004WO2004090163A1 Method of defining the differentiation grade of tumor
10/21/2004WO2004090157A1 The use of pde4d in the screening for medicaments against atherosclerosis
10/21/2004WO2004090145A2 Compounds and methods to enhance raav transduction
10/21/2004WO2004090109A2 Ccn3 compositions and methods
10/21/2004WO2004090106A2 Crystal structures of human pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
10/21/2004WO2004090104A2 Detecting gene expression in live cells using short-lived reporters with enzymatic amplification
10/21/2004WO2004090102A2 Prion protein binding materials and methods of use
10/21/2004WO2004090100A2 Visualizing expression data on chromosomal graphic schemes
10/21/2004WO2004090047A1 Water-based dithiolene infrared inkjet inks
10/21/2004WO2004090031A2 Methods of selecting and developing a particulate material
10/21/2004WO2004089990A1 New monoclonal antibody capable of binding integrin alpha 10 beta 1
10/21/2004WO2004089987A1 Secreted polypeptide species associated with cardiovascular disorders
10/21/2004WO2004089975A2 Peptides of irf-1
10/21/2004WO2004089819A1 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry
10/21/2004WO2004089818A1 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry
10/21/2004WO2004089531A1 Method for immobilizing biomolecules on metal oxide substrates
10/21/2004WO2004089526A2 Methods of providing product consistency
10/21/2004WO2004089423A2 Pharmico-gene theraphy of epithelial sodium channel associated disoders
10/21/2004WO2004089421A2 Methods for rational pegylation of proteins
10/21/2004WO2004089369A2 Methods and means for treating protein conformational disorders
10/21/2004WO2004089310A2 High-throughput assay for virus entry and drug screening
10/21/2004WO2004089295A2 Homogeneous and heterogeneous assay methods using nucleation centers and novel covalent chemistries for the rapid measurement of phosphorylation and de-phosphorylation
10/21/2004WO2004089284A2 Targets for tumor growth inhibition
10/21/2004WO2004089215A1 Visualisation of deposits formed by contact with skin on a substrate
10/21/2004WO2004089187A2 Caries risk test for predicting and assessing the risk of disease
10/21/2004WO2004089184A2 NEW USES OF Lp-PLA2 IN COMBINATION TO ASSESS CORONARY RISK
10/21/2004WO2004089182A2 Anti-retroviral analysis by mass spectrometry
10/21/2004WO2004081721A3 Method and apparatus for pattern identification in diploid dna sequence data
10/21/2004WO2004074990A3 Method for determining sequence alignment significance
10/21/2004WO2004073589A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep4 (prostaglandin e2 ep4)
10/21/2004WO2004073492A3 Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof
10/21/2004WO2004072305A3 Atlastin
10/21/2004WO2004071267A3 Diagnosis of colorectal cancer by detection of nicotinamide n-methyltransferase in a stool sample
10/21/2004WO2004067778A3 Differentially expressed genes in large granular lymphocyte leukemia
10/21/2004WO2004067774A3 Single nucleotide polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy
10/21/2004WO2004067131A3 Improved device and method for separation of blood components
10/21/2004WO2004067026A8 Regulation of allergen induced gene
10/21/2004WO2004062567A3 Arterivirus marker vaccine
10/21/2004WO2004061449A8 Analyzing system for the detection of reducing and oxidizing gases in a carrier gas with a metal-oxide-semiconductor sensor arrangement
10/21/2004WO2004058287A8 Methods of treating neurological conditions with hematopoeitic growth factors
10/21/2004WO2004057341A3 Cvd assay
10/21/2004WO2004056871A3 Peptides and their use for the treatment of hiv infections
10/21/2004WO2004054506A3 Methods and compositions for modulating nf-at transcription factor
10/21/2004WO2004052389A3 Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system
10/21/2004WO2004050909A3 Method to measure a t cell response and its uses to qualify antigen-presenting cells
10/21/2004WO2004047749A3 Purinergic modulation of smell
10/21/2004WO2004046690A3 Composite sensor membrane
10/21/2004WO2004046683A3 Detection of cellular or dna damage based upon hr23 protein binding molecules
10/21/2004WO2004044569B1 Mems membrane based sensor
10/21/2004WO2004044168A3 Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities
10/21/2004WO2004042349A3 Method for evaluating the immunization status of a patient
10/21/2004WO2004042023B1 Stem cell libraries
10/21/2004WO2004037200A3 Reticulocyte depletion signatures
10/21/2004WO2004037189A3 Methods for vaccinating against malaria
10/21/2004WO2004034013A3 Genotoxicity analysis
10/21/2004WO2004025243A3 A method for the identification of drug targets
10/21/2004WO2004023105A3 Personal monitor to detect exposure to toxic agents
10/21/2004WO2004019000A3 Chemical reagents and methods for detection and quantification of proteins in complex mixtures
10/21/2004WO2004016223A3 Assaying compounds or agents for microsomal prostaglandin e synthase or hematopoietic prostaglandin d synthase activity
10/21/2004WO2004013275A8 Stem cells derived from adipous tissue and differentiated cells derived from said cells
10/21/2004WO2003104478A3 Detection of rna structural elements
10/21/2004WO2003104431A3 Transgenic mammals expressing polyglutamine
10/21/2004WO2003099199A3 Compositions and methods for promoting or inhibiting angiogenesis
10/21/2004WO2003094838A3 Simple catalytic dna biosensors for ions based on color changes
10/21/2004WO2003093795A3 Device and method for analytical cell imaging
10/21/2004WO2003093793A3 Binary or polynary targeting and uses thereof
10/21/2004WO2003091835A3 Computationally targeted evolutionary design
10/21/2004WO2003087805A8 Method for efficiently computing the mass of modified peptides for mass spectrometry data-based identification
10/21/2004WO2003086177A3 Method for monitoring the immune response and predicting clinical outcomes in transplant recipients
10/21/2004WO2003085372A8 Biosensor membranes composed of polymers containing heterocyclic nitrogens
10/21/2004WO2003063689A3 Islr gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof
10/21/2004WO2003060081A3 Compositions and methods relating to endometrial specific genes and proteins
10/21/2004WO2003056163A9 Test strip and method for determining hdl cholesterol concentration from whole blood of plasma
10/21/2004WO2003049599A8 Methods and compositions for the diagnosis of asthma
1 ... 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 2260 2261 2262 2263 2264 2265 2266 2267 2268 ... 3937